1. Safety and Immunogenicity Study of NY-ESO-1b Peptide and Montanide ISA-51 Vaccination of Patients with Epithelial Ovarian Cancer in High-Risk First Remission
   Catherine S.M. Diefenbach et al, 2008, Clinical Cancer Research CrossRef